ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation

The constitutively active ESR1 Y537S mutation is associated with endocrine therapy (ET) resistance and progression of metastatic breast cancer through its effects on estrogen receptor (ERα) gene regulatory functions. However, the complex relationship between ERα and the progesterone receptor (PR), k...

Descripción completa

Detalles Bibliográficos
Autores principales: Huggins, Rosemary J., Greene, Geoffrey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689488/
https://www.ncbi.nlm.nih.gov/pubmed/38036546
http://dx.doi.org/10.1038/s41523-023-00601-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689488/
https://www.ncbi.nlm.nih.gov/pubmed/38036546
http://dx.doi.org/10.1038/s41523-023-00601-7

Ejemplares similares